How many insider declarations does 우리바이오 have?

우리바이오 has filed 4 insider declarations with DART (FSS).

Who is the top reporting insider at 우리바이오?

The top reporting insider at 우리바이오 is 우리바이오, based on the count of public filings.

What is the net insider buy vs sell volume on 우리바이오?

Across the available history, declared buys total 0 and disposals 0.

InsidersTradesSigma

← Companies ★ Sign in to follow

우리바이오: directors' dealings · South Korea · DART (FSS)

DART:company-8a6df7KR·DART (FSS)Mcap 96.1Bn€

AMF ↗

Explore the full insider trade history of 우리바이오, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Market capitalisation: €96.1bn. The latest transaction was reported on 7 April 2026 (Sale). Among the most active insiders: 우리바이오. Every trade is openly available.

4

Insider Decl.

0

Thresholds

·

0 ops.

Buy Volume

·

2 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

1922.00 €

Income statement

Revenue1043.96 Bn€

Gross profit95.15 Bn€9% margin

Net income−9.37 Bn€-0.9% margin

Balance sheet & cash

Market cap96.07 Bn€

Total debt127.98 Bn€

Free Cash Flow12.41 Bn€

Last declaration on 7 April 2026

All Executives4 Thresholds Prospectus Other

Declarations0 total

No declarations found

0 of 0 declarations